PF
RMD icon

Phoenix Financial’s ResMed RMD Stock Holding History

Phoenix Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Buy
1,591
+189
+13% +$39.2K ﹤0.01% 425
2026
Q1 		$315K Buy
1,402
+254
+22% +$63.3K ﹤0.01% 375
2025
Q4 		$277K Buy
1,148
+178
+18% +$45.5K ﹤0.01% 397
2025
Q3 		$266K Buy
970
+85
+10% +$23.2K ﹤0.01% 403
2025
Q2 		$228K Buy
+885
New +$211K ﹤0.01% 382
2022
Q4 		– Sell
-2,949
Closed -$646K – 334
2022
Q3 		$646K Buy
2,949
+252
+9% +$57.4K 0.01% 234
2022
Q2 		$566K Buy
2,697
+221
+9% +$47K 0.01% 274
2022
Q1 		$602K Buy
2,476
+1,153
+87% +$279K 0.01% 283
2021
Q4 		$346K Sell
1,323
-283
-18% -$73.4K 0.01% 314
2021
Q3 		$425K Buy
+1,606
New +$439K 0.01% 338
2021
Q2 		– Sell
-1,878
Closed -$356K – 390
2021
Q1 		$356K Sell
1,878
-708
-27% -$142K 0.01% 330
2020
Q4 		$540K Buy
2,586
+1,025
+66% +$204K 0.01% 253
2020
Q3 		$254K Sell
1,561
-1,507
-49% -$278K 0.01% 272
2020
Q2 		$545K Buy
+3,068
New +$502K 0.02% 239

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Phoenix Financial's RMD Position: Q2 2026 in Review

Phoenix Financial increased its ResMed (RMD) stake by 13% in Q2 2026, buying an estimated $39.2K and bringing the position to 1,591 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

Phoenix Financial first reported a position in RMD in Q2 2020 and has held it in 14 quarters since. The position peaked at $646K in Q3 2022. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Phoenix Financial held 1,591 shares of ResMed worth $310K as of Q2 2026.
  • Phoenix Financial bought 189 ResMed shares in Q2 2026, an estimated $39.2K.
  • ResMed made up ﹤0.01% of Phoenix Financial's portfolio in Q2 2026, its #425 holding.
  • Phoenix Financial first reported a position in ResMed in Q2 2020 and has held it in 14 quarters since.
  • Phoenix Financial's ResMed position peaked at $646K in Q3 2022.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.